Is DRNA Stock A Buy or Sell?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
Dicerna Pharmaceuticals Inc (DRNA)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Woodline PartnersKarl Michael Rockefeller And Kroeker | 1,777,000 | $45,438 | +31% | 1% |
| 2. | Aquilo Capital Management Marc Schneidman | 1,705,392 | $43,607 | +26% | 7.88% |
| 3. | Maverick Capital Lee Ainslie | 1,352,802 | $34,591 | 0.31% | |
| 4. | Perceptive Advisors Joseph Edelman | 800,000 | $20,456 | 0.25% | |
| 5. | Point72 Asset Management Steve Cohen | 606,439 | $15,507 | -75% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.06 | 10,000 | Officer, Director | 22,300 | 2020-09-01 | Filing | |
| $7.00 | 285,000 | Large Shareholder, Director | 285,000 | 2017-12-18 | Filing | |
| $3.63 | 16,500 | Officer, Director | 55,579 | 2016-11-15 | Filing | |
| $3.78 | 16,600 | Officer, Director | 39,079 | 2016-11-14 | Filing | |
| $3.29 | 4,170 | Officer | 19,800 | 2016-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.66 | 24 | Officer | 21,517 | 2021-05-03 | Filing | |
| $31.01 | 1,135 | Officer | 21,541 | 2021-05-03 | Filing | |
| $30.16 | 7,153 | Officer | 22,676 | 2021-05-03 | Filing | |
| $31.25 | 475 | Officer | 0 | 2021-05-03 | Filing | |
| $30.17 | 3,956 | Officer | 475 | 2021-05-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 342,540 | $8,758,748 | 0% | |
| 2. | 40,613 | $1,038,474 | 0.01% | |
| 3. | 15,000 | $383,400 | 0% | |
| 4. | 14,117 | $360,972 | 0% | |
| 5. | 7,463,291 | $190,836 | 2.97% |
News See All
Is DRNA A Good Stock To Buy Now According To Hedge Funds?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider...
Is Dicerna Pharmaceuticals (DRNA) a Smart Long-term Buy?
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here. During the third quarter of 2020, the Baron Health Care Fund returned 11.64% (institutional...
Was The Smart Money Wrong About Piling Into Dicerna Pharmaceuticals Inc (DRNA)?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and...
5 Healthcare Stocks the Experts at Aquilo Capital Management Are Buying (1 Has Gained 88% This Month)
Marc Schneidman’s Aquilo Capital Management is a San Francisco-based, healthcare-focused long/short hedge fund that was founded in 2010. The fund uses CIO Schneidman’s 20 years of industry expertise...
Hedge Funds Have Never Been This Bullish On Dicerna Pharmaceuticals Inc (DRNA)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings...
Did Hedge Funds Make The Right Call On Dicerna Pharmaceuticals Inc (DRNA) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful...
Hedge Funds Aren’t Crazy About Dicerna Pharmaceuticals Inc (DRNA) Anymore
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment...
Were Hedge Funds Right About Dicerna Pharmaceuticals Inc (DRNA)?
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the coronavirus...
Hedge Fund and Insider Trading News: David Tepper, Blue Harbour Group, ValueAct Capital, Schmitt Industries, Inc. (SMIT), Continental Resources, Inc. (CLR), and More
Here is how the activist hedge fund fared with its investment in Investors Bancorp, which accounted for 18 percent of its U.S. long assets. Cliff Robbins’ Blue Harbour Group earlier this week unloaded...
Billionaire Hedge Funds
